Status:
COMPLETED
The Impact of Melanoma and Drug Treatment in the Real World
Lead Sponsor:
Vitaccess Ltd
Collaborating Sponsors:
Melanoma UK
Royal Marsden NHS Foundation Trust
Conditions:
Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
An observational, non-interventional registry study to collect real-world data from people living with melanoma and its treatment, which will be available to researchers to further the knowledge of me...
Detailed Description
The registry uses Vitaccess' digital real-world evidence platform, and has been developed in collaboration with the patient advocacy group Melanoma UK. Eligible participants install a study app on th...
Eligibility Criteria
Inclusion
- adults with melanoma of any stage, resident in the UK with National Health Service (NHS) or Community Health Index (CHI) number, aged 18 and over, current or previous diagnosis of melanoma, willing to use their own smartphone or tablet.
Exclusion
- no specific exclusion criteria
Key Trial Info
Start Date :
October 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 6 2021
Estimated Enrollment :
819 Patients enrolled
Trial Details
Trial ID
NCT03379454
Start Date
October 25 2017
End Date
December 6 2021
Last Update
March 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vitaccess Ltd
Oxford, United Kingdom, OX1 1BY